Literature DB >> 17705565

Establishing causality in pediatric adverse drug reactions: use of the Naranjo probability scale.

Marina Avner1, Yaron Finkelstein, Dan Hackam, Gideon Koren.   

Abstract

Carbamazepine hypersensitivity syndrome is a rare, life-threatening condition. Its diagnosis is critical to avoid future exposure to aromatic anticonvulsants. Pediatricians rarely use a systematic approach to establish the cause of drug reactions in the clinical setting. We describe the use of the Naranjo adverse drug reaction probability scale to establish causality in three cases of suspected anticonvulsant hypersensitivity syndrome with the aim of introducing clinicians to this effective tool. Our analysis reveals that this method is useful, but also highlights potential areas for its improvement.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17705565     DOI: 10.2165/00148581-200709040-00007

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  11 in total

Review 1.  Mechanisms of drug reactions: the metabolic track.

Authors:  L E Shapiro; N H Shear
Journal:  Semin Cutan Med Surg       Date:  1996-12

Review 2.  Anticonvulsant hypersensitivity syndrome: incidence, prevention and management.

Authors:  S R Knowles; L E Shapiro; N H Shear
Journal:  Drug Saf       Date:  1999-12       Impact factor: 5.606

Review 3.  The diagnosis of adverse medical events associated with drug treatment.

Authors:  M D Stephens
Journal:  Adverse Drug React Acute Poisoning Rev       Date:  1987

4.  Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.

Authors:  N H Shear; S P Spielberg
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

5.  Anticonvulsant hypersensitivity syndrome.

Authors:  C C Vittorio; J J Muglia
Journal:  Arch Intern Med       Date:  1995-11-27

6.  Comparison of the Bayesian approach and a simple algorithm for assessment of adverse drug events.

Authors:  K L Lanctôt; C A Naranjo
Journal:  Clin Pharmacol Ther       Date:  1995-12       Impact factor: 6.875

7.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

Review 8.  Anticonvulsant hypersensitivity syndrome.

Authors:  A R Morkunas; M B Miller
Journal:  Crit Care Clin       Date:  1997-10       Impact factor: 3.598

9.  Acute respiratory failure mediated by reactive drug metabolites.

Authors:  D Murphy; J B Kronick; M J Rieder
Journal:  Biol Neonate       Date:  1995

10.  Phenytoin hypersensitivity: 38 cases.

Authors:  F Haruda
Journal:  Neurology       Date:  1979-11       Impact factor: 9.910

View more
  7 in total

1.  Hepatotoxicity induced by trimethoprim-sulfamethoxazole in a child with cystic fibrosis.

Authors:  Ibrahim Abdulhamid; Victoria Tutag Lehr
Journal:  J Pediatr Pharmacol Ther       Date:  2014-01

2.  QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine.

Authors:  Katie Malone; Jules C Hancox
Journal:  Ther Adv Drug Saf       Date:  2020-08-17

3.  Initial anticonvulsant monotherapy in routine care of children and adolescents: levetiracetam fails more frequently than valproate and oxcarbazepine due to a lack of effectiveness.

Authors:  Astrid Bertsche; Martina P Neininger; Anna J Dahse; Steffen Syrbe; Matthias K Bernhard; Roberto Frontini; Wieland Kiess; Thilo Bertsche; Andreas Merkenschlager
Journal:  Eur J Pediatr       Date:  2013-08-11       Impact factor: 3.183

4.  Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool.

Authors:  Ruairi M Gallagher; Jamie J Kirkham; Jennifer R Mason; Kim A Bird; Paula R Williamson; Anthony J Nunn; Mark A Turner; Rosalind L Smyth; Munir Pirmohamed
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

5.  Utilization of the Naranjo scale to evaluate adverse drug reactions at a free-standing children's hospital.

Authors:  Madhavi Murali; Sarah L Suppes; Keith Feldman; Jennifer L Goldman
Journal:  PLoS One       Date:  2021-01-13       Impact factor: 3.240

Review 6.  Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions.

Authors:  Lateef M Khan; Sameer E Al-Harthi; Abdel-Moneim M Osman; Mai A Alim A Sattar; Ahmed S Ali
Journal:  Saudi Pharm J       Date:  2015-01-10       Impact factor: 4.330

7.  Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy.

Authors:  Jyoti Bhagatram Sharma; Manjunath Nookala Krishnamurthy; Ankita Awase; Amit Joshi; Vijay Patil; Vanita Noronha; Kumar Prabhash; Vikram Gota
Journal:  Ther Adv Drug Saf       Date:  2021-02-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.